The global Implantable Drug-Eluting Devices Market is expected to reach USD 22.22 Biliion by the end of 2032, with a valuation of USD 13.27 Biliion in 2023, according to a report released by Zion Market Research. Over the course of the projected period, the market is anticipated to expand at a CAGR of 5.9%. The study examines the factors driving and limiting the global Implantable Drug-Eluting...